Crown Laboratories, Inc. is a privately held, fully integrated global skin care company. We are committed to developing and providing a diverse portfolio of beauty, therapeutic and aesthetic skin care products that improve the quality of life for our customers. In addition, Crown Laboratories also provides pharmaceutical development and contract manufacturing services for a host of partners world-wide. As an innovative company with key products such as its recently acquired, first FDA-cleared medical grade microneedling device, SkinPen, Blue Lizard Australian Sunscreen, PanOxyl, Vita Liberata sunless tanning and skin care, and robust portfolio of Rx and OTC products, Crown Laboratories has enjoyed rapid growth and is poised to become a leader in Dermatology. In addition, we have been listed on the Inc. 5000 Fastest Growing Companies List for seven years.
Location: United States, Tennessee, Johnson City
Employees: 201-500
Phone: +1 423-926-4413
Founded date: 2000
Investors 1
| Date | Name | Website |
| - | Hildred | hildred.co... |
Mentions in press and media 27
| Date | Title | Description |
| 07.02.2025 | Crown Laboratories Completes Acquisition of Revance Therapeutics | NEW YORK--(BUSINESS WIRE)--Yesterday, Crown Laboratories, Inc. ("Crown"), a Hildred Capital portfolio company and privately held, global innovative leader in the skincare industry, announced the closing of its acquisition of Revan... |
| 09.12.2024 | Crown Laboratories and Revance Enter into Amended and Restated Merger Agreement | JOHNSON CITY, Tenn. and NASHVILLE, Tenn., Dec. 9, 2024 /PRNewswire/ -- Crown Laboratories, Inc. ("Crown"), a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc. ("Revance") (... |
| 06.11.2024 | CROWN AESTHETICS PROVIDES CAVENDISH CLINICS WITH AWARD-WINNING SKINPEN® PRECISION TO UPGRADE ITS MICRONEEDLING DEVICE OFFERING | LONDON, Nov. 6, 2024 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories company and leading innovator in the dermatologic and aesthetics industry, is proud to announce that Cavendish Clinics, one of the United Kingdom's ("UK")... |
| 16.09.2024 | Ben Samit Appointed Managing Director at Hildred Capital Management | NEW YORK--(BUSINESS WIRE)--Hildred Capital Management (“Hildred”), a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies, today announced that Ben Samit has been appointed a Managing Di... |
| 03.09.2024 | Crown Aesthetics Announces FDA Clearance of New SkinPen® Precision Elite | The first FDA-Cleared microneedling treatment and category leader in dermatology and aesthetics continues to build its legacy with best-in-class technology DALLAS, Sept. 3, 2024 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories company... |
| 12.08.2024 | Crown Laboratories and Revance Announce Entry Into Merger Agreement | Combination provides opportunity to create a leading, innovative, high-growth aesthetics and skincare company Brings together two high-quality, complementary product lines Combined company's flagship brands to include DAXXIFY® (toxin), the ... |
| 27.06.2024 | Crown Laboratories, Inc. and BIOJUVE® Celebrate World Microbiome Day 2024 | Embracing the Power of the Skin Microbiome with BIOJUVE JOHNSON CITY, Tenn., June 27, 2024 /PRNewswire/ -- Microbiome research has revolutionized our understanding of human health, highlighting the vital role our body's microbiome plays in ... |
| 26.02.2024 | Wael Fayad and Stephen Hallenbeck Appointed Partners at Hildred Capital Management | NEW YORK--(BUSINESS WIRE)--Hildred Capital Management (“Hildred”), a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies, today announced that Wael Fayad and Stephen Hallenbeck have bot... |
| 24.05.2022 | Crown Laboratories Expands Aesthetics' Portfolio With Acquisition Of Eclipse Medcorp, Llc Assets | JOHNSON CITY, Tenn., May 24, 2022 /PRNewswire/ -- Crown Laboratories ("Crown"), a leading, fully integrated global skincare company, has finalized an agreement with Eclipse, a medical technology company, to acquire its global, aes... |
| 15.02.2022 | Hildred Capital Management Closes Hildred Equity Partners II Fund at $363 Million | NEW YORK--(BUSINESS WIRE)--Hildred Capital Management LLC (“Hildred”), a New York based private equity firm, today announced that it has closed its first institutional fund, Hildred Equity Partners II (the “Fund”) with total commitments of ... |
Show more